510(k) K030754
K030754 is an FDA 510(k) premarket notification submitted by Anticancer, Inc. for the device "A/C ENZYMATIC HOMOCYSTEINE ASSAY". The FDA issued a decision of Substantially Equivalent on Jul 11, 2003. The device falls under product code LPS (Urinary Homocystine (Nonquantitative) Test System), a Class II device regulated under 21 CFR 862.1377. Anticancer, Inc. has 2 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jul 11, 2003
- Date Received
- Mar 10, 2003
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Urinary Homocystine (Nonquantitative) Test System
- Device Class
- Class II
- Regulation Number
- 862.1377
- Review Panel
- CH
- Submission Type
- 510(k)
Need the full FDA record for Anticancer, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.